TSCAN THERAPEUTICS INC's ticker is and the CUSIP is 89854M101. A total of 81 filers reported holding TSCAN THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 1.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DC Funds, LP | 630,000 | $3,685,500 | 61.20% |
| Lynx1 Capital Management LP | 5,224,600 | $30,563,910 | 11.03% |
| Propel Bio Management, LLC | 2,087,139 | $12,209,763 | 7.92% |
| Deer Management Co. LLC | 1,245,504 | $7,286,198 | 1.50% |
| STEMPOINT CAPITAL LP | 845,069 | $4,943,654 | 1.45% |
| GREAT POINT PARTNERS LLC | 940,831 | $5,503,861 | 1.05% |
| EcoR1 Capital, LLC | 5,000,000 | $29,250,000 | 0.90% |
| BVF INC/IL | 2,989,474 | $17,488,423 | 0.49% |
| Simplify Asset Management Inc. | 1,046,916 | $6,124,459 | 0.41% |
| Alphabet Inc. | 1,077,080 | $6,300,918 | 0.32% |